相关实验视频
Updated: Jun 19, 2025

07:08
The Lambda Select cII Mutation Detection System
Published on: April 26, 2018
7.9K
智能技术的应用在对突变致病性的评估中
Jia Li1, Wenli Xu1, Wenchao Zhang2
1Key Laboratory of Fluorine and Nitrogen Chemistry and Advanced Materials (Chinese Academy of Sciences), Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 200032, China.
概括
智能评估方法,比如CISOC-PSMT艾姆斯测试预测系统,可以替代传统的生物测试来评估变异性. 这种方法提高了数据质量和在各种安全和发现领域的战略应用.
科学领域:
- 毒理学 毒理学 毒理学
- 计算化学计算化学
- 风险评估 风险评估
背景情况:
- 生物测试是致变性测试的标准,但可能是资源密集的.
- 智能评估方法利用数据质量,战略和技术进行替代评估.
- 艾姆斯试验是基因突变性的一个关键生物试验.
研究的目的:
- 介绍突变性评估中智能评估的策略和技术.
- 引入CISOC-PSMT,一个艾姆斯测试预测系统.
- 突出CISOC-PSMT在不同领域的应用.
主要方法:
- 开发和应用智能评估策略.
- 使用CISOC-PSMT系统进行艾姆斯测试预测.
- 展示系统应用的案例研究.
主要成果:
- CISOC-PSMT为智能艾姆斯测试预测提供了一个框架.
- 在多个应用领域中证明了系统的实用性.
- 增强对数据驱动的突变性评估方法的理解.
结论:
- 智能评估,以CISOC-PSMT为例,为传统生物测试提供了一个可行的替代方案.
- CISOC-PSMT系统在农药管理,环境保护,药物发现和化学安全方面具有广泛的适用性.
- 这种方法支持化学风险评估中的知情决策.
相关概念视频
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
In-vitro Mutagenesis
13.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.9K

